I recently bought some Liberty Health Sciences Inc. stock. If my sources were correct and I believe there were, I was amazed to read that from their inception in 2014 through to and including 2017 they had no income to report. 2018 will be the first fiscal year that they realized some income. A whole lot of R & D and capital goods expenditures later, I think they want to show us what they've got.
It took awhile but things are looking up IMO. Researching the best that I could, I have gleaned that they still have approx. $25m in cash and very little debt., and currently the capacity to supply about 10-15% of the Fla. medical cannabis market. Additionally, they have seemingly quality products with name recognition and are about to quadruple their production facilities in the coming months per company bulletins. Again IMO, the lack of legal recreational MJ sales in Fla. will curtail blockbuster sales. But I am wondering with the forthcoming improved production capacity if they can't start exporting product soon. I know that they are looking at licensing agreements in other states. Canada has production limitations presently; perhaps Canada, too. Wouldn't that help the cash flow.
